Follow the Brooks Laboratories Limited share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares are listed on IN IN, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Brooks Laboratories Limited has published 9 insider filings. Market capitalisation: €1.9bn. The latest transaction was reported on 15 November 2024 (Sale). Among the most active insiders: Atul Ranchal. All data is openly available.
9
Insider Decl.
0
Thresholds
€235,830
5 ops.
Buy Volume
€2m
4 ops.
Sell Volume
10Σ signal
Buys €235,830€2m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 1,852 of 26,134 companies
76.7
score / 100
Value
73
Quality
81
FCF yld2.8%
Earn yld12%
EV/EBITDA8.0x
ROE22%
Gross mgn40%
Net mgn29%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.